Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Delsol

Showing results (251-260 of 268) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric OncologyL Brugières, P Quartier, M C Le Deley, et al.
Blood|April 16, 1998
ALK-positive lymphoma: a single disease with a broad spectrum of morphologyD Benharroch, Z Meguerian-Bedoyan, L Lamant, et al.
American Journal of Clinical Pathology|May 1, 1995
A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary versionJ K Chan, P M Banks, M L Cleary, et al.
Histopathology|December 1, 1994
A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group)J K Chan, P M Banks, M L Cleary, et al.
British Journal of Haematology|April 7, 1999
Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four casesC Bayle, A Charpentier, E Duchayne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphomaF Morschhauser, C Recher, N Milpied, et al.
Blood|November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALKB Falini, K Pulford, A Pucciarini, et al.
The American Journal of Pathology|August 1, 1996
Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosisM Beylot-Barry, L Lamant, B Vergier, et al.
Virology|April 1, 1995
Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B)E Kremmer, B R Kranz, A Hille, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)T Rüdiger, E S Jaffe, G Delsol, et al.
Pageof 27

Showing results (251-260 of 268) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric OncologyL Brugières, P Quartier, M C Le Deley, et al.
Blood|April 16, 1998
ALK-positive lymphoma: a single disease with a broad spectrum of morphologyD Benharroch, Z Meguerian-Bedoyan, L Lamant, et al.
American Journal of Clinical Pathology|May 1, 1995
A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary versionJ K Chan, P M Banks, M L Cleary, et al.
Histopathology|December 1, 1994
A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group)J K Chan, P M Banks, M L Cleary, et al.
British Journal of Haematology|April 7, 1999
Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four casesC Bayle, A Charpentier, E Duchayne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphomaF Morschhauser, C Recher, N Milpied, et al.
Blood|November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALKB Falini, K Pulford, A Pucciarini, et al.
The American Journal of Pathology|August 1, 1996
Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosisM Beylot-Barry, L Lamant, B Vergier, et al.
Virology|April 1, 1995
Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B)E Kremmer, B R Kranz, A Hille, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)T Rüdiger, E S Jaffe, G Delsol, et al.
Pageof 27